+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ameluz"

Actinic Keratosis Treatment Market Report 2025 - Product Thumbnail Image

Actinic Keratosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Actinic Keratosis Treatment Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Actinic Keratosis Treatment Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 140 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Ameluz market is a segment of the skin cancer drugs market. It is composed of products that are used to treat actinic keratosis, a precancerous skin condition. These products are typically topical creams or gels that contain aminolevulinic acid, a photosensitizing agent. When exposed to light, the agent causes the destruction of abnormal cells. The Ameluz market is a growing segment of the skin cancer drugs market, as it offers a safe and effective treatment for actinic keratosis. Companies in the Ameluz market include Galderma, Sun Pharmaceuticals, and Biofrontera. Galderma is a Swiss-based pharmaceutical company that produces the Ameluz brand of topical cream. Sun Pharmaceuticals is an Indian-based company that produces the Solaraze brand of topical gel. Biofrontera is a German-based company that produces the BF-RhodoLED brand of topical gel. Show Less Read more